Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy.
Nat Chem Biol. 2021 May;17(5):567-575. doi: 10.1038/s41589-021-00742-5. Epub 2021 Mar 4.
Nat Chem Biol. 2021.
PMID: 33664520
PROTAC mediated FKBP12 degradation enhances Hepcidin expression via BMP signaling without immunosuppression activity.
Zhong T, Sun X, Yu L, Liu Y, Lin X, Rao Y, Wu W.
Zhong T, et al.
Signal Transduct Target Ther. 2022 May 27;7(1):163. doi: 10.1038/s41392-022-00970-8.
Signal Transduct Target Ther. 2022.
PMID: 35618726
Free PMC article.
No abstract available.
Item in Clipboard
Correction: PROTAC mediated FKBP12 degradation enhances Hepcidin expression via BMP signaling without immunosuppression activity.
Zhong T, Sun X, Yu L, Liu Y, Lin X, Rao Y, Wu W.
Zhong T, et al.
Signal Transduct Target Ther. 2022 Jun 22;7(1):197. doi: 10.1038/s41392-022-01051-6.
Signal Transduct Target Ther. 2022.
PMID: 35732621
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite